Minimal Stent Area: New IVUS Parameter?

Intravascular Ultrasound (IVUS) has shown, in several studies, its great benefits for both restenosis and mortality reduction.  

Área mínima del stent ¿es un nuevo parámetro para tener en cuenta en el IVUS?

Even though several variables have been studied, so far minimal stent area (MSA) has been disregarded as important. 

The OPTIVUS-Complex PCI looked at 961 patients with 1,957 lesions, and found 1.6% TLR incidence (30 lesions).

There were no significant differences between patients presenting TLR and those who did, except for a higher incidence of hemodialysis in the second group. 

As regards the procedure, there were no differences in pre and post dilation, lesion complexity, chronic occlusions, vessel diameter, QCA, lesion length, or proximal reference area. 

Time from PCI to TLR was 251 days (167-325), and 73% happened after 180 days. 

Read also: Association Between Radial Wall Strain (RWS) and Risk of Acute Myocardial Infarction.

66.7% of TLR was ischemia driven. 

Even though hemodialysis and MSA were more frequent in TLR patients, the difference did not reach statistical significance. 

Conclusion

At present, TLR incidence after IVUS guided PCI at one year is quite low. Minimal stent area, but not other stent expansion criteria, has been associated with TLR upon multivariable analysis. Independent factors were calcified lesions and small proximal reference lumen area. Therefore, these findings should be interpreted with caution, seeing the low number of TLR events, the limited number of complex lesions and the short followup. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.

Reference: Yamamoto, et al. Circ Cardiovasc Interv.2023;16:e012922.DOI:10.1161/CIRCINTERVENTIONS.123.012922.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...